Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study

…, M Migliori, R Giusti, A Lippi, A Casani… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Resistance to erythropoiesis-stimulating agents (ESAs) is often associated with
chronic inflammation. Here, we investigated how anaemia, ESA resistance and the plasma …

High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the …

…, M Migliori, D Caiani, C Tetta, A Casani… - Nephrology Dialysis …, 2015 - academic.oup.com
Background In haemodialysis (HD) patients, anaemia is associated with reduced survival.
Despite treatment with erythropoiesis-stimulating agents (ESAs), a large number of patients …

A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients …

…, M Migliori, S Beati, G Bernabini, R Daini, A Casani… - Blood purification, 2011 - karger.com
Background: Oxidative stress is prevalent in dialysis patients and has been implicated in the
pathogenesis of cardiovascular disease and anemia. Vitamin E is a fat-soluble antioxidant …

Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study “Hephaestus”

…, V Miniello, M Migliori, C Grimaldi, A Casani… - Journal of …, 2021 - Springer
Background Studies addressing the anti-inflammatory properties of citrate dialysate enrolled
patients in both hemodialysis (HD) and hemodiafiltration (HDF), the latter not adjusted for …

Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study …

…, S David, P Sala, A Icardi, A Casani - American journal of kidney …, 2006 - Elsevier
Background: Previous studies reported significant increases in epoetin dosages when converting
hemodialysis patients from subcutaneous (SC) to intravenous (IV) administration. More …

A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study

…, M Migliori, S Paoletti, G Manca Rizza, A Casani… - Blood …, 2015 - karger.com
Background: A pharmacoeconomic analysis of the RISCAVID database aimed at assessing
the cost effectiveness of phosphate binders in preventing CV mortality and morbidity over 7 …

Cost and effectiveness of 2 years integrated care intervention in COPD

…, T Pianta, B Marsiglia, M Polselli, A Macuzzi, A Casani… - 2015 - Eur Respiratory Soc
Implementation of disease integrated care intervention (ICI) might improve the clinical outcomes
and decrease the economic burden in COPD Aim: The effect ICI on hospital admission …

[CITATION][C] Increased kidney accumulation of 131I-lysozyme in the uninephrectomized rat

…, C Vannucci, V Ricchiuti, A Casani… - Kidney, Proteins and …, 1993 - karger.com
Materials and Methods Lysozyme LZM (MW 14,300, pI 11.0), obtained from chicken egg
white (SPA, Italy), was iodinated with 131I (IRE, Belgium) using the chloramine-T method [5]. …

A disease-specific integrated care intervention (ICI) prevents hospital admission only in COPD patients with recurrent hospitalisation

…, A Macuzzi, B Marsiglia, A Casani… - European …, 2014 - Eur Respiratory Soc
Introduction COPD is characterised by an increased risk of hospital readmission due to
recurrent acute exacerbations (AECOPD). The effectiveness of ICI at preventing hospitalisations …